Found: 58
Select item for more details and to access through your institution.
Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48077-8
- By:
- Publication type:
- Article
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 1, p. 144, doi. 10.1093/cid/ciad445
- By:
- Publication type:
- Article
Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-up.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 1, p. 164, doi. 10.1093/cid/ciad589
- By:
- Publication type:
- Article
COVID-19 in Patients with Drug-Resistant Tuberculosis in Lesotho.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2023, v. 109, n. 5, p. 1205, doi. 10.4269/ajtmh.23-0422
- By:
- Publication type:
- Article
Respiratory, Cardiac, and Neuropsychiatric Manifestations of Postacute Sequelae of Coronavirus Disease 2019 in Lima, Peru.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 7, p. 1, doi. 10.1093/ofid/ofad320
- By:
- Publication type:
- Article
Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 207, n. 11, p. 1525, doi. 10.1164/rccm.202211-2125OC
- By:
- Publication type:
- Article
Ascertainment Bias in TB Treatment Trials Can Systematic Assessment of Objective Endpoints Solve It?
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 207, n. 10, p. 1269, doi. 10.1164/rccm.202303-0430ED
- By:
- Publication type:
- Article
Low detection rate of RT-PCR-confirmed COVID-19 using IgM/IgG rapid antibody tests in a large community sample in Lima, Peru.
- Published in:
- BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08003-7
- By:
- Publication type:
- Article
Prevention and management of hearing loss in patients receiving ototoxic medications.
- Published in:
- Bulletin of the World Health Organization, 2022, v. 100, n. 12, p. 789, doi. 10.2471/BLT.21.286823
- By:
- Publication type:
- Article
Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion.
- Published in:
- PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0276457
- By:
- Publication type:
- Article
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 8, p. 1307, doi. 10.1093/cid/ciac176
- By:
- Publication type:
- Article
Clinical Outcomes of Individuals with COVID-19 and Tuberculosis during the Pre-Vaccination Period of the Pandemic: A Systematic Review.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 19, p. 5656, doi. 10.3390/jcm11195656
- By:
- Publication type:
- Article
Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different.
- Published in:
- PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0271102
- By:
- Publication type:
- Article
Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies Among Market and City Bus Depot Workers in Lima, Peru.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 2, p. 343, doi. 10.1093/cid/ciab323
- By:
- Publication type:
- Article
The Reductionist Conundrum of an "Updated" Definition of Extensively Drug-resistant Tuberculosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
INCIDENCE OF HIGH GRADE QTCF PROLONGATION AND ITS MANAGEMENT AMONG PATIENTS UNDERGOING TREATMENT FOR DRUG RESISTANT TUBERCULOSIS (DR-TB): CASE SERIES.
- Published in:
- African Journal of Infectious Diseases, 2021, v. 15, p. 38, doi. 10.21010/ajidv15i2S.5
- By:
- Publication type:
- Article
Time-Dependent Confounding in Tuberculosis Treatment Outcome Analyses: A Review of a Source of Bias.
- Published in:
- 2020
- By:
- Publication type:
- letter
Comparison of censoring assumptions to reduce bias in tuberculosis treatment cohort analyses.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0240297
- By:
- Publication type:
- Article
Nepali Linguistic Validation of the Velopharyngeal Insufficiency Effects on Life Outcomes Instrument: VELO-Nepali.
- Published in:
- Cleft Palate Craniofacial Journal, 2020, v. 57, n. 8, p. 967, doi. 10.1177/1055665620905173
- By:
- Publication type:
- Article
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reply to te Brake et al.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2019, v. 199, n. 9, p. 1167, doi. 10.1164/rccm.201812-2281LE
- By:
- Publication type:
- Article
Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Asthma and atopy prevalence are not reduced among former tuberculosis patients compared with controls in Lima, Peru.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reply to te Brake : Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
- Published in:
- 2019
- By:
- Publication type:
- letter
Use of predicted vital status to improve survival analysis of multidrug-resistant tuberculosis cohorts.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reply.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2017, v. 196, n. 11, p. 1490, doi. 10.1164/rccm.201705-0988LE
- By:
- Publication type:
- Article
An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Fluoroquinolone Resistance Mutation Detection Is Equivalent to Culture-Based Drug Sensitivity Testing for Predicting Multidrug-Resistant Tuberculosis Treatment Outcome: A Retrospective Cohort Study.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 8, p. 1364, doi. 10.1093/cid/cix556
- By:
- Publication type:
- Article
A Bayesian response-adaptive trial in tuberculosis: The endTB trial.
- Published in:
- Clinical Trials, 2017, v. 14, n. 1, p. 17, doi. 10.1177/1740774516665090
- By:
- Publication type:
- Article
Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations.
- Published in:
- 2016
- By:
- Publication type:
- letter
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0155968
- By:
- Publication type:
- Article
Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis.
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 7, p. 887, doi. 10.1093/cid/ciw002
- By:
- Publication type:
- Article
Propensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non- Standardized Treatment for Multidrug Resistant Tuberculosis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0151724
- By:
- Publication type:
- Article
Acquired and Transmitted Multidrug Resistant Tuberculosis: The Role of Social Determinants.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0146642
- By:
- Publication type:
- Article
Issues in design and interpretation of MDR-TB clinical trials: report of the first Global MDR-TB Clinical Trials Landscape Meeting.
- Published in:
- BMC Proceedings, 2015, v. 9, p. 1, doi. 10.1186/1753-6561-9-S8-S1
- By:
- Publication type:
- Article
The need to accelerate access to new drugs for multidrug-resistant tuberculosis.
- Published in:
- Bulletin of the World Health Organization, 2015, v. 93, n. 7, p. 491, doi. 10.2471/BLT.14.138925
- By:
- Publication type:
- Article
Counting Pyrazinamide in Regimens for Multidrug-Resistant Tuberculosis.
- Published in:
- Annals of the American Thoracic Society, 2015, v. 12, n. 5, p. 674, doi. 10.1513/AnnalsATS.201411-538OC
- By:
- Publication type:
- Article
Time to Culture Conversion and Regimen Composition in Multidrug-Resistant Tuberculosis Treatment.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0108035
- By:
- Publication type:
- Article
Improving Outcomes for Multidrug-Resistant Tuberculosis: Aggressive Regimens Prevent Treatment Failure and Death.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 1, p. 9, doi. 10.1093/cid/ciu209
- By:
- Publication type:
- Article
Concordance of Resistance Profiles in Households of Patients With Multidrug-Resistant Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 3, p. 392, doi. 10.1093/cid/cit709
- By:
- Publication type:
- Article
Principles for designing future regimens for multidrug-resistant tuberculosis.
- Published in:
- Bulletin of the World Health Organization, 2014, v. 92, n. 1, p. 68, doi. 10.2471/BLT.13.122028
- By:
- Publication type:
- Article
Aggressive Regimens for Multidrug-Resistant Tuberculosis Reduce Recurrence.
- Published in:
- Clinical Infectious Diseases, 2013, v. 56, n. 6, p. 770, doi. 10.1093/cid/cis1008
- By:
- Publication type:
- Article
Aggressive Regimens for Multidrug-Resistant Tuberculosis Decrease All-Cause Mortality.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058664
- By:
- Publication type:
- Article
A Systematic Review of Reported Cost for Smear and Culture Tests during Multidrug-Resistant Tuberculosis Treatment.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056074
- By:
- Publication type:
- Article
Old Drugs, New Purpose: Retooling Existing Drugs for Optimized Treatment of Resistant Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. 4, p. 572
- By:
- Publication type:
- Article
Preliminary clinical outcomes from the Peruvian National Cataract Elimination Plan.
- Published in:
- Pan American Journal of Public Health / Revista Panamericana de Salud Pública, 2010, v. 28, n. 4, p. 282, doi. 10.1590/S1020-49892010001000007
- By:
- Publication type:
- Article
Recurrence after Treatment for Pulmonary Multidrug-Resistant Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2010, v. 51, n. 6, p. 709, doi. 10.1086/655892
- By:
- Publication type:
- Article
Treatment Outcomes among Patients with Extensively Drug-Resistant Tuberculosis: Systematic Review and Meta-Analysis.
- Published in:
- Clinical Infectious Diseases, 2010, v. 51, n. 1, p. 6, doi. 10.1086/653115
- By:
- Publication type:
- Article